Superinvestor buys and sells
10,737 buys and sells in the latest 13F filings of the investors tracked here, largest first. The largest is Anand Desai's new position in SPCX, $17.3B or 78% of the reported portfolio.
Key facts
- Moves
- 10,737
- New positions
- 1250
- Complete sales
- 1968
- Largest move
- SPCX, $17.3B
- Investors
- 153
- Latest filing
- Nov 16, 2026
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Stock | Move | Shares | Size | Of portfolio | Quarter |
|---|---|---|---|---|---|---|---|
| 4301 | John Overdeck and David Siegel (founders) | J P Morgan Exchange TradedBBCA | ▼ Sold out | — | $22.4M | 0.02% | Q3 2026 |
| 4302 | Cathie Wood | CareDx IncCDNA | ▼ Reduced 18% | −344.39K | $22.4M | 0.13% | Q3 2026 |
| 4303 | Charles Brandes (founder) | Amdocs LtdDOX | ▲ Added 8.5% | +391.28K | $22.4M | 0.15% | Q3 2026 |
| 4304 | Andreas Halvorsen | Visa IncV | ▲ Added 1.0% | +65.18K | $22.4M | 0.06% | Q2 2026 |
| 4305 | Ken Fisher | Mitsubishi Ufj Financial GMUFG | ▲ Added 1.0% | +969.34K | $22.4M | 0.01% | Q3 2026 |
| 4306 | Louis Bacon | Carrier Global CorpCARR | ▲ New | +407.47K | $22.4M | 0.63% | Q3 2026 |
| 4307 | George Soros | American Healthcare REIT IncAHR | ▼ Sold out | — | $22.4M | 0.34% | Q3 2026 |
| 4308 | Louis Bacon | Select Sector SPDR TrustXLP | ▼ Sold out | — | $22.3M | 0.63% | Q3 2026 |
| 4309 | Christopher Davis | Trip.com Group LtdTCOM | ▲ Added 6.5% | +571.26K | $22.3M | 0.10% | Q3 2026 |
| 4310 | Jonathan Litt | Prologis IncPLD | ▼ Sold out | — | $22.3M | 3.82% | Q2 2026 |
| 4311 | John Overdeck and David Siegel (founders) | ROBLOX CorpRBLX | ▲ Added 3.9% | +525.83K | $22.3M | 0.02% | Q3 2026 |
| 4312 | Louis Bacon | QXO IncQXO | ▼ Sold out | — | $22.3M | 0.63% | Q3 2026 |
| 4313 | Baillie Gifford team | Eqt CorpEQT | ▲ Added 8.4% | +458.61K | $22.3M | 0.02% | Q3 2026 |
| 4314 | Steve Cohen | Madison Square Garden EntmtMSGE | ▼ Reduced 15% | −275.14K | $22.3M | 0.03% | Q2 2026 |
| 4315 | Paul Tudor Jones | Snowflake IncSNOW | ▼ Sold out | — | $22.2M | 0.09% | Q2 2026 |
| 4316 | Bill Smead | Western Alliance BancorpWAL | ▲ Added 19% | +295.64K | $22.2M | 0.47% | Q3 2026 |
| 4317 | Eric Mandelblatt | American Electric Power Co. IncAEP | ▼ Reduced 14% | −162.26K | $22.2M | 0.16% | Q2 2026 |
| 4318 | Peter Kolchinsky | Travere Therapeutics IncTVTX | ▼ Sold out | — | $22.2M | 0.19% | Q2 2026 |
| 4319 | Joel Greenblatt | Amkor Technology IncAMKR | ▼ Reduced 24% | −257.17K | $22.2M | 0.05% | Q2 2026 |
| 4320 | Dodge & Cox team | The Cigna GroupCI | ▲ Added 0.7% | +81.57K | $22.2M | 0.01% | Q3 2026 |
| 4321 | Bill Nygren | Workday IncWDAY | ▲ Added more than 10× | +181.1K | $22.2M | 0.03% | Q2 2026 |
| 4322 | Adam Katz | Compass IncCOMP | ▲ New | +1.8M | $22.2M | 1.59% | Q2 2026 |
| 4323 | Julian and Felix Baker | Immunocore Holdings plcIMCR | ▼ Sold out | — | $22.1M | 0.11% | Q2 2026 |
| 4324 | Peter Kolchinsky | Grail IncGRAL | ▼ Sold out | — | $22.1M | 0.19% | Q2 2026 |
| 4325 | Josef Lakonishok | Bristol-Myers Squibb CoBMY | ▼ Reduced 3.6% | −354.68K | $22.1M | 0.04% | Q3 2026 |
| 4326 | Howard Marks | Quantum CorpQMCO | ▲ New | +2.01M | $22.1M | 0.42% | Q2 2026 |
| 4327 | John Rogers | Fiserv IncFISV | ▼ Reduced 90% | −489.69K | $22.1M | 0.23% | Q3 2026 |
| 4328 | Pat Dorsey | S&P Global IncSPGI | ▲ Added 18% | +56.04K | $22.1M | 1.29% | Q3 2026 |
| 4329 | Temasek | DPC Holdings PLCDPC | ▼ Sold out | — | $22.1M | 0.06% | Q3 2026 |
| 4330 | Howard Gleicher | Cameco CorpCCJ | ▼ Reduced 24% | −254.56K | $22.1M | 0.05% | Q3 2026 |
| 4331 | Barry Rosenstein | Fiserv IncFISV | ▲ Added 13% | +488.16K | $22.1M | 1.39% | Q3 2026 |
| 4332 | Paul Tudor Jones | Allegion PLCALLE | ▼ Reduced 40% | −156.93K | $22M | 0.09% | Q2 2026 |
| 4333 | Bryan Lawrence | Martin Marietta MaterialsMLM | ▲ New | +45.95K | $22M | 8.40% | Q3 2026 |
| 4334 | John Rogers | Madison Square Garden EntmtMSGE | ▼ Reduced 5.2% | −275.2K | $22M | 0.23% | Q3 2026 |
| 4335 | Diamond Hill team | Thermo Fisher Scientific IncTMO | ▼ Reduced 13% | −32.66K | $22M | 0.24% | Q3 2026 |
| 4336 | George Soros | Medline IncMDLN | ▼ Reduced 39% | −634.78K | $22M | 0.34% | Q3 2026 |
| 4337 | Jensen team | Cadence Design Systems IncCDNS | ▼ Reduced 22% | −66.71K | $22M | 0.69% | Q3 2026 |
| 4338 | Charles Brandes (founder) | UBS Group AGUBS | ▼ Reduced 33% | −457.63K | $22M | 0.15% | Q3 2026 |
| 4339 | Mason Hawkins | CNX Resources CorpCNX | ▲ Added 16% | +649.06K | $22M | 1.15% | Q2 2026 |
| 4340 | Chase Coleman | UnitedHealth Group IncUNH | ▼ Reduced 15% | −52.99K | $22M | 0.09% | Q2 2026 |
| 4341 | Louis Bacon | Tenet Healthcare CorpTHC | ▼ Sold out | — | $22M | 0.62% | Q3 2026 |
| 4342 | Baillie Gifford team | Recursion Pharmaceuticals IncRXRX | ▼ Reduced 23% | −5.31M | $21.9M | 0.02% | Q3 2026 |
| 4343 | Thomas Russo | Berkshire Hathaway IncBRK-B | ▼ Reduced 4.1% | −44.04K | $21.9M | 0.26% | Q3 2026 |
| 4344 | Andreas Halvorsen | Fervo Energy CoFRVO | ▲ New | +750K | $21.9M | 0.06% | Q2 2026 |
| 4345 | George Soros | Atkore Incno ticker on file | ▲ New | +231.15K | $21.9M | 0.34% | Q3 2026 |
| 4346 | Cathie Wood | GeneDx Holdings CorpWGS | ▲ Added 19% | +302.89K | $21.9M | 0.13% | Q3 2026 |
| 4347 | Gavin Baker | Snowflake IncSNOW | ▼ Sold out | — | $21.8M | 0.20% | Q2 2026 |
| 4348 | Stanley Druckenmiller | Jabil IncJBL | ▼ Sold out | — | $21.8M | 0.50% | Q2 2026 |
| 4349 | Ken Fisher | Blackrock IncBLK | ▼ Reduced 1.5% | −20.63K | $21.8M | 0.01% | Q3 2026 |
| 4350 | Howard Gleicher | Select Sector SPDR TrustXLY | ▲ New | +200.4K | $21.8M | 0.05% | Q3 2026 |
| 4351 | Ken Fisher | Rio Tinto PLCRIO | ▲ Added 1.1% | +231.58K | $21.8M | 0.01% | Q3 2026 |
| 4352 | Baillie Gifford team | Brookfield CorpBN | ▼ Reduced 10% | −597.84K | $21.8M | 0.02% | Q3 2026 |
| 4353 | Andrew Spokes | KKR & Co. IncKKR | ▼ Reduced 5.8% | −238.46K | $21.8M | 0.11% | Q3 2026 |
| 4354 | Joel Greenblatt | Lululemon Athletica IncLULU | ▲ Added 58% | +190.66K | $21.8M | 0.05% | Q2 2026 |
| 4355 | Rajiv Jain | Eni SpaE | ▼ Reduced 68% | −400.41K | $21.7M | 0.04% | Q3 2026 |
| 4356 | Tweedy, Browne team | Ionis Pharmaceuticals IncIONS | ▼ Reduced 21% | −486.83K | $21.7M | 1.77% | Q3 2026 |
| 4357 | Baillie Gifford team | Rivian Automotive IncRIVN | ▼ Reduced 3.4% | −1.45M | $21.7M | 0.02% | Q3 2026 |
| 4358 | Paul Tudor Jones | First Horizon CorporationFHN | ▲ Added 187% | +845.37K | $21.7M | 0.09% | Q2 2026 |
| 4359 | Gavin Baker | Visa IncV | ▼ Sold out | — | $21.7M | 0.19% | Q2 2026 |
| 4360 | Glen Kacher | MercadoLibre IncMELI | ▲ New | +12.75K | $21.6M | 2.54% | Q2 2026 |
| 4361 | Cliff Asness | Mckesson CorpMCK | ▼ Reduced 3.2% | −28.77K | $21.6M | 0.01% | Q2 2026 |
| 4362 | Andrew Spokes | AstraZeneca PLCAZN | ▼ Reduced 23% | −133.96K | $21.6M | 0.11% | Q3 2026 |
| 4363 | Ron Baron | DraftKings IncDKNG | ▼ Reduced 30% | −1.14M | $21.6M | 0.04% | Q3 2026 |
| 4364 | Paul Tudor Jones | ServiceNow IncNOW | ▲ Added 49% | +217.42K | $21.6M | 0.09% | Q2 2026 |
| 4365 | Matthew McLennan | Ambiq Micro IncAMBQ | ▼ Sold out | — | $21.6M | 0.03% | Q3 2026 |
| 4366 | Joel Greenblatt | Roper Technologies IncROP | ▲ Added 44% | +63.76K | $21.6M | 0.05% | Q2 2026 |
| 4367 | Paul Tudor Jones | Hershey CoHSY | ▼ Sold out | — | $21.6M | 0.09% | Q2 2026 |
| 4368 | Josef Lakonishok | Ford MTR CoF | ▲ Added 10% | +1.79M | $21.6M | 0.04% | Q3 2026 |
| 4369 | Bill Smead | Lennar CorpLEN | ▲ Added 13% | +264.28K | $21.6M | 0.46% | Q3 2026 |
| 4370 | John Overdeck and David Siegel (founders) | Wave Life Sciences LtdWVE | ▼ Sold out | — | $21.5M | 0.02% | Q3 2026 |
| 4371 | Paul Tudor Jones | Vanguard Energy Etf - US ETPVDE | ▼ Sold out | — | $21.5M | 0.09% | Q2 2026 |
| 4372 | Diamond Hill team | ESAB CorpESAB | ▲ Added 62% | +326.95K | $21.5M | 0.23% | Q3 2026 |
| 4373 | Louis Bacon | CSX CorpCSX | ▼ Reduced 38% | −462.92K | $21.5M | 0.61% | Q3 2026 |
| 4374 | Louis Bacon | Boston Scientific CorpBSX | ▲ Added 260% | +492.61K | $21.5M | 0.61% | Q3 2026 |
| 4375 | Mairs & Power team | UnitedHealth Group IncUNH | ▼ Reduced 10% | −58.57K | $21.5M | 0.20% | Q3 2026 |
| 4376 | Julian and Felix Baker | Abcellera Biologics IncABCL | ▲ Added 9.0% | +2.74M | $21.5M | 0.11% | Q2 2026 |
| 4377 | Charles Brandes (founder) | Mobility Global IncMBGL | ▲ New | +1.25M | $21.5M | 0.15% | Q3 2026 |
| 4378 | Jeremy Grantham (co-founder) | Leidos Holdings IncLDOS | ▲ Added 301% | +176.15K | $21.5M | 0.05% | Q3 2026 |
| 4379 | Matthew McLennan | Kinross Gold CorpKGC | ▼ Reduced 14% | −891.05K | $21.5M | 0.03% | Q3 2026 |
| 4380 | Larry Robbins | Surgery Partners IncSGRY | ▼ Sold out | — | $21.5M | 0.43% | Q2 2026 |
| 4381 | Temasek | Tencent Music Entertainment GroupTME | ▼ Sold out | — | $21.4M | 0.06% | Q3 2026 |
| 4382 | Paul Tudor Jones | Expedia Group IncEXPE | ▼ Sold out | — | $21.4M | 0.09% | Q2 2026 |
| 4383 | Howard Marks | Barrick Mining CorpB | ▲ Added 22% | +581.16K | $21.3M | 0.40% | Q2 2026 |
| 4384 | Chuck Royce (founder) | Aaon IncAAON | ▲ Added 67% | +257.81K | $21.3M | 0.19% | Q3 2026 |
| 4385 | Brandon Haley | NU Holdings LtdNU | ▲ Added 29% | +1.6M | $21.3M | 0.05% | Q2 2026 |
| 4386 | Baillie Gifford team | Lemonade IncLMND | ▼ Reduced 17% | −472.62K | $21.3M | 0.02% | Q3 2026 |
| 4387 | Baillie Gifford team | Mastercard IncMA | ▼ Reduced 2.2% | −38.68K | $21.3M | 0.02% | Q3 2026 |
| 4388 | George Soros | Middleby CorpMIDD | ▼ Sold out | — | $21.3M | 0.33% | Q3 2026 |
| 4389 | George Soros | Topbuild Corno ticker on file | ▼ Sold out | — | $21.3M | 0.33% | Q3 2026 |
| 4390 | George Soros | Macerich CoMAC | ▼ Reduced 49% | −951.62K | $21.3M | 0.33% | Q3 2026 |
| 4391 | Stanley Druckenmiller | Entegris IncENTG | ▲ New | +118.3K | $21.3M | 0.49% | Q2 2026 |
| 4392 | Andreas Halvorsen | Aon PLCAON | ▲ Added 5.9% | +64.14K | $21.3M | 0.06% | Q2 2026 |
| 4393 | Thomas Kahn | Shake Shack IncSHAK | ▲ New | +362.32K | $21.3M | 3.53% | Q3 2026 |
| 4394 | Frank Sands | On Holding AGONON | ▼ Reduced 9.6% | −717.84K | $21.3M | 0.09% | Q3 2026 |
| 4395 | Boaz Weinstein | Blackrock Tech and PrivateBTX | ▲ Added 308% | +2.35M | $21.2M | 0.65% | Q2 2026 |
| 4396 | Bill Miller (founder) | Concentrix CorpCNXC | ▲ New | +851.13K | $21.2M | 4.60% | Q3 2026 |
| 4397 | Howard Gleicher | Mckesson CorpMCK | ▲ New | +24.87K | $21.2M | 0.05% | Q3 2026 |
| 4398 | John Overdeck and David Siegel (founders) | Ionis Pharmaceuticals IncIONS | ▲ Added 7.6% | +475.17K | $21.2M | 0.02% | Q3 2026 |
| 4399 | Steven Romick | Broadcom IncAVGO | ▼ Reduced 95% | −60.23K | $21.2M | 0.25% | Q3 2026 |
| 4400 | Diamond Hill team | Gates Indl Corp PLCGTES | ▼ Sold out | — | $21.1M | 0.23% | Q3 2026 |
Questions and answers
What did superinvestors buy last quarter?
The largest purchases in the latest 13F filings: SPCX (Anand Desai), $17.3B; IVV (Ken Griffin), $10.2B; SPY (David Shaw (founder)), $9.9B; GOOGL (Warren Buffett), $8.8B; GOOG (Warren Buffett), $8.3B; SPCX (Gavin Baker), $4.7B.
What did superinvestors sell last quarter?
The largest sales in the latest 13F filings: Electronic Arts Inc (Saudi Public Investment Fund), $5.1B; PM (Rajiv Jain), $4.8B; MU (Ken Griffin), $4.6B; MU (David Shaw (founder)), $3.3B; IEF (Ken Fisher), $3.1B; ENB (Rajiv Jain), $2.7B.
How is the size of a buy or sell worked out?
As the change in shares at the price the filing implies for the quarter's end (reported value divided by shares) — an estimate of the trade, not what was paid. A position sold out is sized at its value in the previous filing.
Learn
Cite this page
Funkfolio, “Superinvestor buys and sells”, data as of 16 November 2026. https://funkfolio.com/gurus/activity
Underlying data: SEC EDGAR, Form 13F-HR.
Source: SEC EDGAR, Form 13F-HR. A move is a change in share count between an investor's latest filing and the one before; a share split in between is allowed for where one is on record. Size is the shares bought or sold at the price the filing implies for the period end (reported value ÷ shares) — an estimate of the trade, not what was paid — and a position sold out is sized at its value in the previous filing. “Of portfolio” sets that size against the portfolio reported for the period. Only each investor's 150 largest positions and 50 largest exits are read. Filings appear up to 45 days after the quarter ends; none of this is advice.